Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation (NIPPV)
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy.

British journal of clinical pharmacology·2024
Same author

The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?

Journal of aerosol medicine and pulmonary drug delivery·2022
Same author

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2019
Same author

Why have trials of inhaled antibiotics for ventilator-associated infections failed?

Current opinion in infectious diseases·2019
Same author

Inhaled Antibiotics for Ventilator-Associated Infections.

Infectious disease clinics of North America·2017
Same author

Is There a Role for Inhaled Antibiotics in the Treatment of Ventilator-Associated Infections?

Seminars in respiratory and critical care medicine·2017

Related Experiment Video

Updated: Jun 23, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Ventilator-associated infection.

Lucy B Palmer1

  • 1Pulmonary Critical Care Division, SUNY at Stony Brook, Stony Brook, New York 11794-8172, USA. lbpalmer@notes.cc.sunysb.edu

Current Opinion in Pulmonary Medicine
|April 24, 2009
PubMed
Summary
This summary is machine-generated.

Ventilator-associated pneumonia (VAP) and ventilator-associated tracheobronchitis (VAT) are serious infections in critical care. New treatments show promise, but complete elimination of these infections remains unlikely due to impaired host defenses.

Related Experiment Videos

Last Updated: Jun 23, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Area of Science:

  • Critical care medicine
  • Infectious diseases
  • Pulmonology

Background:

  • Ventilator-associated pneumonia (VAP) is a significant concern in critically ill patients.
  • Diagnostic accuracy and preventability of VAP are subjects of ongoing debate.
  • Understanding pathogenesis is key to managing respiratory tract infections in ventilated patients.

Purpose of the Study:

  • To review the pathophysiology of respiratory tract infections in ventilated patients.
  • To explore how recent advances align with current understanding of VAP pathogenesis.
  • To discuss new approaches to treatment and bacterial resistance challenges.

Main Methods:

  • Review of recent investigations focusing on proximal airway infection (VAT).
  • Analysis of data on reducing morbidity from airway colonization to VAP.
  • Evaluation of interventions like subglottic secretion suctioning and targeted VAT therapy.

Main Results:

  • Recent trials highlight the role of ventilator-associated tracheobronchitis (VAT) in respiratory tract infections.
  • Continuous subglottic secretion suctioning and innovative endotracheal tubes show promise.
  • Despite interventions, complete elimination of VAT and VAP is unlikely due to impaired host defenses and antibiotic resistance.

Conclusions:

  • The pathogenesis of VAT and VAP, modifiable risk factors, and treatment approaches are crucial areas of focus.
  • Bacterial resistance poses a significant challenge in managing these infections.
  • Impaired host defenses in intubated patients necessitate ongoing vigilance and research.